Menu

woman getting her blood pressure measured

Communicable Disease Prevention

Building leaders and strategies to reduce communicable disease

Our Impact

See all Communicable Disease Prevention Impacts

community worker distributing masks
  • 27K Central American youth received sexual health information
  • 100 physicians convened in India to combat antibiotic resistance
  • 10M pieces of personal protective equipment delivered in CA and WA in 3 weeks to protect against COVID-19

Our Work

From sexually transmitted infections to outbreaks of Ebola, Zika and other viruses, communicable diseases are a major threat to the public’s health. We apply our expertise in research, leadership development, evaluation, capacity building and technological innovation to combat the spread of communicable disease in the U.S. and around the world.

PHI Priority

Building Health Equity

Young women in sub-Saharan Africa are disproportionately impacted by HIV and other sexually transmitted infections as well as high rates of unintended pregnancy, and are among the most underserved populations for sexual and reproductive health in the world. In 2022, PHI's CAMI Health and partners spoke to young women and key influencers in their communities (male partners, grandmothers and technical experts) about their sexual and reproductive health experiences. Their first-hand stories provide glimpses into the diversity of their needs and desires and offer insights into solutions for improving their lives. Serving as an advocacy tool for female-initiated HIV prevention and family planning options, the StoryMap tool aims to foster the adoption of Multipurpose Prevention Technologies (MPTs) as potential game-changers in addressing these issues.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org